Pub. Date : 2019
PMID : 30971955
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Treatment with gliclazide 10 mg/kg reduced MPO activity (p < 0.001), MDA levels (p < 0.001) and NFkappaB NLS P50 (p < 0.05) protein levels, resulting in low immunostaining to Cox-2, iNOS (p < 0.05), NFkappaB P65 (p < 0.05), and negative immunoreaction to MMP-2 (p < 0.001). | Gliclazide | myeloperoxidase | Homo sapiens |